Glass samples in Li 2 O-SiO 2 -CaO-P 2 O 5 -CaF 2 system with different contents of P 2 O 5 , CaO and CaF 2 in relative ratios responded to fluoroapatite (FA) composition (referred to P 2 O 5 addition) have been prepared and heat treated at 550 and 750uC to obtain glass ceramics. Bioactivity of all samples has been proved in vitro by the presence of new layer of apatite-like phases formed after soaking in simulated body fluid (SBF). The development and the apatitic character of created layers have been demonstrated by Fourier transform infrared analysis. Scanning electron microscopy and electron probe microanalysis have demonstrated that the density and the thickness of new layer depend on P 2 O 5 content, crystallisation temperature and immersion time. The bioactivity has been enhanced by P 2 O 5 addition as well in the case of the base glasses as in the case of glass ceramics. The additional heat treatment appeared to inhibit the bioactive behaviour, though the longer SBF acting leads to the additional formation of apatite-like layer. The mechanical properties, expressed as Vicker hardness, have been found higher and increasing with P 2 O 5 in glass ceramics treated at 750uC comparatively with base glass samples and the highest value of 7?37 GPa has been achieved by 14 wt-%P 2 O 5 addition. The same content of P 2 O 5 in glass ceramics heat treated at 550uC resulted in a decrease in hardness to a minimum value from all samples. The increase and decrease in hardness responded to development and suppression of crystallisation respectively. The inhibition of crystallisation has been affected by the presence of 'amorphous' FA according to X-ray diffraction and differential thermal analysis results.